Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
Menichincheri M, Ardini E, Magnaghi P, Avanzi N, Banfi P, Bossi R, Buffa L, Canevari G, Ceriani L, Colombo M, Corti L, Donati D, Fasolini M, Felder E, Fiorelli C, Fiorentini F, Galvani A, Isacchi A, Borgia AL, Marchionni C, Nesi M, Orrenius C, Panzeri A, Pesenti E, Rusconi L, Saccardo MB, Vanotti E, Perrone E, Orsini P. Menichincheri M, et al. Among authors: perrone e. J Med Chem. 2019 Sep 12;62(17):8364. doi: 10.1021/acs.jmedchem.9b01259. Epub 2019 Aug 19. J Med Chem. 2019. PMID: 31424209 No abstract available.
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
Menichincheri M, Ardini E, Magnaghi P, Avanzi N, Banfi P, Bossi R, Buffa L, Canevari G, Ceriani L, Colombo M, Corti L, Donati D, Fasolini M, Felder E, Fiorelli C, Fiorentini F, Galvani A, Isacchi A, Borgia AL, Marchionni C, Nesi M, Orrenius C, Panzeri A, Pesenti E, Rusconi L, Saccardo MB, Vanotti E, Perrone E, Orsini P. Menichincheri M, et al. Among authors: perrone e. J Med Chem. 2016 Apr 14;59(7):3392-408. doi: 10.1021/acs.jmedchem.6b00064. Epub 2016 Mar 30. J Med Chem. 2016. PMID: 27003761
6-Substituted pyrrolo[3,4-c]pyrazoles: an improved class of CDK2 inhibitors.
Brasca MG, Albanese C, Amici R, Ballinari D, Corti L, Croci V, Fancelli D, Fiorentini F, Nesi M, Orsini P, Orzi F, Pastori W, Perrone E, Pesenti E, Pevarello P, Riccardi-Sirtori F, Roletto F, Roussel P, Varasi M, Vulpetti A, Mercurio C. Brasca MG, et al. Among authors: perrone e. ChemMedChem. 2007 Jun;2(6):841-52. doi: 10.1002/cmdc.200600302. ChemMedChem. 2007. PMID: 17450625
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis.
Perrone E, Capasso I, Giannarelli D, Trozzi R, Congedo L, Ervas E, Tarantino V, Esposito G, Palmieri L, Guaita A, van Rompuy AS, Scaglione G, Zannoni GF, Scambia G, Amant F, Fanfani F. Perrone E, et al. Gynecol Oncol. 2024 Oct 17;191:150-157. doi: 10.1016/j.ygyno.2024.10.010. Online ahead of print. Gynecol Oncol. 2024. PMID: 39423552
The impact of Substantial LYMphovascular space invasion on sentinel lymph nodes status and recurrence in Endometrial Cancer patients: SLYM-EC a multicenter retrospective study.
Buda A, Fruscio R, Mauro J, Imboden S, De Ponti E, Perrone E, Grassi T, Bruno V, Garcia-Pineda V, Taskin S, Restaino S, Siegenthaler F, Casarin J, Raimondo D, Capozzi VA, Vatansever D, Capasso I, Vizza E, Gungor M, Zapardiel I, Papadia A, Taskiran C, Fanfani F, Vizzielli G, Scambia G, Mueller M. Buda A, et al. Among authors: perrone e. Eur J Surg Oncol. 2024 Oct 3;50(12):108731. doi: 10.1016/j.ejso.2024.108731. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39418834
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides.
Baum RP, Novruzov E, Zhao T, Greifenstein L, Jakobsson V, Perrone E, Mishra A, Eismant A, Ghai K, Klein O, Jaeschke B, Benz-Zils D, Cardinale J, Mori Y, Giesel FL, Zhang J. Baum RP, et al. Among authors: perrone e. Semin Nucl Med. 2024 Jul;54(4):537-556. doi: 10.1053/j.semnuclmed.2024.05.010. Epub 2024 Jul 16. Semin Nucl Med. 2024. PMID: 39019653 Review.
233 results